PPT-Ataxia Drug Treatments: Targets and Pipeline

Author : singh | Published Date : 2022-06-15

Susan L Perlman MD Clinical Professor of Neurology at UCLA DISCLAIMER PRESENTER DISCLOSURES Susan L Perlman MD The following personal financial relationships with

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Ataxia Drug Treatments: Targets and Pipe..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Ataxia Drug Treatments: Targets and Pipeline: Transcript


Susan L Perlman MD Clinical Professor of Neurology at UCLA DISCLAIMER PRESENTER DISCLOSURES Susan L Perlman MD The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months. Dr Rakesh Shukla. Professor Of Neurology. Definition. Ataxia (Gk. Taxis = Order; means lack of order). Ataxia denotes a syndrome of imbalance and . incoordination involving gait, limbs, and speech and . (Louis-Bar syndrome). Tauris Claiborne. The DDR cascade leads to DNA repair or apoptosis. Domain Structure of Human ATM. Autophosphorylation. of ATM at serine 1981 is required for stabilized retention to . Dr Rakesh Shukla. Professor Of Neurology. Definition. Ataxia (Gk. Taxis = Order; means lack of order). Ataxia denotes a syndrome of imbalance and . incoordination involving gait, limbs, and speech and . The Ataxias : Research in FRDA, SCA, MSA Susan L. Perlman M.D. Clinical Professor of Neurology David Geffen School of Medicine at UCLA 3/8/2015 NAF AMM Denver Disclaimer The information provided by speakers in any presentation made as part of the 2015 NAF Annual Membership Meeting is for informational use only. Dalmo. . Mendonca. Neuroscience. April 1st, 2011. Overview. What is up with . polyglutamine. ?. Cerebellar Ataxia & Digestion?. Is stem cell treatment within our reach?. Polyglutamine. Alone?. Mutations that cause repeat . MSA. Susan L. Perlman M.D.. Clinical Professor of Neurology. David Geffen School of Medicine at UCLA. 3/8/2015. NAF AMM Denver. Disclaimer. The information provided by speakers in any presentation made as part of the 2015 NAF Annual Membership Meeting is for informational use only.. Professor of Neurology and Pediatrics – Stanford University. Disclaimer. The information provided by speakers in any presentation made as part of the 2016 NAF Annual Ataxia Conference is for informational use only.. Dra. Nelly . Luza. Residente Neurología Infantil . HCSBA- Universidad de Chile. SUI- Enero 2017. Introducción . Caffarelli. M.. . Topical Review Acute . Ataxia in Children: A Review of the Differential . Dr Julie Vallortigara. Forward with Hope . Overview. Ataxia UK Research strategy. Advances in diagnosis. CA therapeutic strategies. Latest CA trials. Taking part in research. Ataxia UK Research strategy. Susan L. Perlman M.D.. Clinical Professor of Neurology. David Geffen School of Medicine at UCLA. Disclaimer. The information provided by speakers in any presentation made as part of the 2016 NAF Annual Ataxia Conference is for informational use only.. Professor of Neurology. ATAXIA CLINIC. Oriented to diagnostic process more than therapeutic. New patient evaluations. Complete history and physical exam, past . hx. , ROS. Common problems in ataxia: gait, speech, upper limb problems, visual symptoms.. Friedreich’s ataxia research update. Therapeutic targets in FA. Clinical research. Trials in FA. Taking part in research. International ataxia research conference 2017. Overview. Ataxia. Mutated. gene in FA switched off. Dr Julie Greenfield. Forward with Hope . Overview. Ataxia UK Research strategy. FA therapeutic strategies. Latest FA trials. Taking part in research. Ataxia UK Research strategy. Launched mid 2018. Aim: . What can we accomplish with more than 2X revenue and 2X workforce?. Social Media Coordinator. Chief Scientific Officer. Clinical Services Manager. Database Manager. Support Group / Programs Coordinator.

Download Document

Here is the link to download the presentation.
"Ataxia Drug Treatments: Targets and Pipeline"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents